Naong, Jhoan O.

HRN: 13-14-05  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
CEFUROXIME 1.5GM (VIAL)
05/28/2023
05/29/2023
IV
1.5gm
Q8 3 Doses
Post LTCS
Waiting Final Action 
05/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/28/2023
05/29/2023
IV
500mg
Q8 3 Doses
Post LTCS
Waiting Final Action 
05/29/2023
CEFUROXIME 500MG (TAB)
05/29/2023
06/05/2023
PO
500mg
Bid
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: